SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-042785
Filing Date
2010-05-03
Accepted
2010-05-03 16:49:30
Documents
10
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c98019e10vq.htm 10-Q 553259
2 EXHIBIT 31.1 c98019exv31w1.htm EX-31.1 6126
3 EXHIBIT 31.2 c98019exv31w2.htm EX-31.2 6397
4 EXHIBIT 32.1 c98019exv32w1.htm EX-32.1 2567
5 EXHIBIT 32.2 c98019exv32w2.htm EX-32.2 2864
  Complete submission text file 0000950123-10-042785.txt   2434111

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20100331.xml EX-101.INS 381698
7 EX-101 SCHEMA DOCUMENT celg-20100331.xsd EX-101.SCH 14133
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20100331_cal.xml EX-101.CAL 42324
9 EX-101 LABELS LINKBASE DOCUMENT celg-20100331_lab.xml EX-101.LAB 154125
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20100331_pre.xml EX-101.PRE 86693
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16132 | Film No.: 10793626
SIC: 2834 Pharmaceutical Preparations